Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIMABOTULINUMTOXINB vs RISEDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIMABOTULINUMTOXINB vs RISEDRONATE: Safety Overview

Metric RIMABOTULINUMTOXINB RISEDRONATE
Total FAERS Reports 176 6,768
Deaths Reported 38 202
Death Rate 21.6% 3.0%
Hospitalizations 35 1,825
Average Patient Age 59.0 yrs 68.0 yrs
% Female Patients 68.6% 92.3%
FDA Approval Date N/A Apr 14, 2000
Manufacturer Solstice Neurosciences, LLC Aurobindo Pharma Limited
Route INTRAMUSCULAR ORAL
Marketing Status N/A Discontinued